The Mining of Toxin-Like Polypeptides from EST Database by Single Residue Distribution Analysis Sergey Kozlov, Eugene Grishin*
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Anemonia Viridis Venom: Coupling Biochemical Purification
marine drugs Review The Anemonia viridis Venom: Coupling Biochemical Purification and RNA-Seq for Translational Research Aldo Nicosia 1,*,† , Alexander Mikov 2,†, Matteo Cammarata 3, Paolo Colombo 4 , Yaroslav Andreev 2,5, Sergey Kozlov 2 and Angela Cuttitta 1,* 1 National Research Council-Institute for the Study of Anthropogenic Impacts and Sustainability in the Marine Environment (IAS-CNR), Laboratory of Molecular Ecology and Biotechnology, Capo Granitola, Via del mare, Campobello di Mazara (TP), 91021 Sicily, Italy 2 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, GSP-7, ul. Miklukho-Maklaya, 16/10, 117997 Moscow, Russia; [email protected] (A.M.); [email protected] (Y.A.); [email protected] (S.K.) 3 Department of Earth and Marine Sciences, University of Palermo, 90100 Palermo, Italy; [email protected] 4 Istituto di Biomedicina e di Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Via Ugo La Malfa 153, 90146 Palermo, Italy; [email protected] 5 Institute of Molecular Medicine, Ministry of Healthcare of the Russian Federation, Sechenov First Moscow State Medical University, 119991 Moscow, Russia * Correspondence: [email protected] (A.N.); [email protected] (A.C.); Tel.: +39-0924-40600 (A.N. & A.C.) † These authors have made equal contribution. Received: 29 September 2018; Accepted: 24 October 2018; Published: 25 October 2018 Abstract: Blue biotechnologies implement marine bio-resources for addressing practical concerns. The isolation of biologically active molecules from marine animals is one of the main ways this field develops. Strikingly, cnidaria are considered as sustainable resources for this purpose, as they possess unique cells for attack and protection, producing an articulated cocktail of bioactive substances. -
Marine Drugs ISSN 1660-3397 © 2006 by MDPI
Mar. Drugs 2006, 4, 70-81 Marine Drugs ISSN 1660-3397 © 2006 by MDPI www.mdpi.org/marinedrugs Special Issue on “Marine Drugs and Ion Channels” Edited by Hugo Arias Review Cnidarian Toxins Acting on Voltage-Gated Ion Channels Shanta M. Messerli and Robert M. Greenberg * Marine Biological Laboratory, 7 MBL Street, Woods Hole, MA 02543, USA Tel: 508 289-7981. E-mail: [email protected] * Author to whom correspondence should be addressed. Received: 21 February 2006 / Accepted: 27 February 2006 / Published: 6 April 2006 Abstract: Voltage-gated ion channels generate electrical activity in excitable cells. As such, they are essential components of neuromuscular and neuronal systems, and are targeted by toxins from a wide variety of phyla, including the cnidarians. Here, we review cnidarian toxins known to target voltage-gated ion channels, the specific channel types targeted, and, where known, the sites of action of cnidarian toxins on different channels. Keywords: Cnidaria; ion channels; toxin; sodium channel; potassium channel. Abbreviations: KV channel, voltage-gated potassium channel; NaV, voltage-gated sodium channel; CaV, voltage-gated calcium channel; ApA, Anthopleurin A; ApB, Anthopleurin B; ATX II, Anemone sulcata toxin II; Bg II, Bunodosoma granulifera toxin II; Sh I, peptide neurotoxin I from Stichodactyla helianthus; RP II, polypeptide toxin II from Radianthus paumotensis; RP III, polypeptide toxin III from Radianthus paumotensis; RTX I, neurotoxin I from Radianthus macrodactylus; PaTX, toxin from Paracicyonis actinostoloides; Er I, peptide toxin I from Entacmaea ramsayi; Da I, peptide toxin I from Dofleinia armata; ATX III, Anemone sulcata toxin III; ShK, potassium channel toxin from Stichodactyla helianthus; BgK, potassium channel toxin from Bunodosoma granulifera; AsKS, kalciceptine from Anemonia sulcata; HmK, potassium channel toxin from Heteractis magnifica; AeK, potassium channel toxin from Actinia equina; AsKC 1-3, kalcicludines 1-3 from Anemonia sulcata; BDS-I, BDS-II, blood depressing toxins I and II Mar. -
Focus on Scorpion Toxins
ISSN 0006-2979, Biochemistry (Moscow), 2015, Vol. 80, No. 13, pp. 1764-1799. © Pleiades Publishing, Ltd., 2015. Original Russian Text © A. I. Kuzmenkov, E. V. Grishin, A. A. Vassilevski, 2015, published in Uspekhi Biologicheskoi Khimii, 2015, Vol. 55, pp. 289-350. REVIEW Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins A. I. Kuzmenkov*, E. V. Grishin, and A. A. Vassilevski* Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia; E-mail: [email protected]; [email protected] Received June 16, 2015 Revision received July 21, 2015 Abstract—Potassium (K+) channels are a widespread superfamily of integral membrane proteins that mediate selective transport of K+ ions through the cell membrane. They have been found in all living organisms from bacteria to higher mul- ticellular animals, including humans. Not surprisingly, K+ channels bind ligands of different nature, such as metal ions, low molecular mass compounds, venom-derived peptides, and antibodies. Functionally these substances can be K+ channel pore blockers or modulators. Representatives of the first group occlude the channel pore, like a cork in a bottle, while the second group of ligands alters the operation of channels without physically blocking the ion current. A rich source of K+ channel ligands is venom of different animals: snakes, sea anemones, cone snails, bees, spiders, and scorpions. More than a half of the known K+ channel ligands of polypeptide nature are scorpion toxins (KTx), all of which are pore blockers. These com- pounds have become an indispensable molecular tool for the study of K+ channel structure and function. A recent special interest is the possibility of toxin application as drugs to treat diseases involving K+ channels or related to their dysfunction (channelopathies). -
Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds
marine drugs Review Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds 1,2, 3, 3, Rocio K. Finol-Urdaneta * , Aleksandra Belovanovic y, Milica Micic-Vicovac y, Gemma K. Kinsella 4, Jeffrey R. McArthur 1 and Ahmed Al-Sabi 3,* 1 Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW 2522, Australia; jeff[email protected] 2 Electrophysiology Facility for Cell Phenotyping and Drug Discovery, Wollongong, NSW 2522, Australia 3 College of Engineering and Technology, American University of the Middle East, Kuwait; [email protected] (A.B.); [email protected] (M.M.-V.) 4 School of Food Science and Environmental Health, College of Sciences and Health, Technological University Dublin, D07 ADY7 Dublin, Ireland; [email protected] * Correspondence: rfi[email protected] (R.K.F.-U.); [email protected] (A.A.-S.); Tel.: +965-22251400 (ext.1798) (A.A.-S.) These authors contributed equally to this review. y Received: 3 February 2020; Accepted: 16 March 2020; Published: 20 March 2020 Abstract: Toxins from marine animals provide molecular tools for the study of many ion channels, including mammalian voltage-gated potassium channels of the Kv1 family. Selectivity profiling and molecular investigation of these toxins have contributed to the development of novel drug leads with therapeutic potential for the treatment of ion channel-related diseases or channelopathies. Here, we review specific peptide and small-molecule marine toxins modulating Kv1 channels and thus cover recent findings of bioactives found in the venoms of marine Gastropod (cone snails), Cnidarian (sea anemones), and small compounds from cyanobacteria. -
Biochemical and Electrophysiological Characterization of Two Sea Anemone Type 1 Potassium Toxins from a Geographically Distant Population Ofbunodosoma Caissarum
Mar. Drugs 2013, 77, 655-679; doi:10.3390/mdl 1030655 OPEN ACCESS Marine Drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Article Biochemical and Electrophysiological Characterization of Two Sea Anemone Type 1 Potassium Toxins from a Geographically Distant Population ofBunodosoma caissarum Diego J. B. Orts 1,2, Steve Peigneur 3, Bruno Madio Juliana S. Cassoli4, Gabriela G. Montandon 4, Adriano M. C. Pimenta 4, José E. P. W. Bicudo \ José C. Freitas \ André J. Zaharenko 5’* and Jan Tytgat3’* 1 Department of Physiology, Institute of Biosciences, University of Sao Paulo, Sao Paulo, SP, 05508-090, Brazil; E-Mails: [email protected] (D.J.B.O.); [email protected] (B.M.); [email protected] (J.E.P.W.B.); [email protected] (J.C.F.) 9 Center of Marine Biology, University of Sao Paulo, Sao Sebastiäo, SP, 11600-000, Brazil Laboratory of Toxicology, University of Leuven (K.U. Leuven), Campus Gasthuisberg 0&N2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium; E-Mail: [email protected] 4 Laboratory of Venoms and Animals Toxins, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil; E-Mails: [email protected] (J.S.C.); [email protected] (G.G.M.); [email protected] (A.M.C.P.) 5 Laboratorio de Genetica, Instituto Butantan, Sao Paulo, SP, 05503-900, Brazil * Authors to whom correspondence should be addressed; E-Mails: [email protected] (A.J.Z.); [email protected] (J.T.); Tel.: +55-11-2627-9721 (A.J.Z.); Fax: +55-11-3083-2838 (A.J.Z.); Tel.: +32-1632-3407 (J.T.); Fax: +32-1632-3405 (J.T.). -
Sea Anemone Toxins: a Structural Overview
Review Sea Anemone Toxins: A Structural Overview Bruno Madio 1,* Glenn F. King 1 and Eivind A. B. Undheim 2,3 1 Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia; [email protected] 2 Centre for Advanced Imaging, The University of Queensland, St. Lucia, QLD 4072, Australia; [email protected] 3 Centre for Ecology and Evolutionary Synthesis, Department of Biosciences, University of Oslo, 0316 Oslo, Norway * Correspondence: [email protected] Received: 24 April 2019; Accepted: 25 May 2019; Published: 1 June 2019 Abstract: Sea anemones produce venoms of exceptional molecular diversity, with at least 17 different molecular scaffolds reported to date. These venom components have traditionally been classified according to pharmacological activity and amino acid sequence. However, this classification system suffers from vulnerabilities due to functional convergence and functional promiscuity. Furthermore, for most known sea anemone toxins, the exact receptors they target are either unknown, or at best incomplete. In this review, we first provide an overview of the sea anemone venom system and then focus on the venom components. We have organised the venom components by distinguishing firstly between proteins and non-proteinaceous compounds, secondly between enzymes and other proteins without enzymatic activity, then according to the structural scaffold, and finally according to molecular target. Keywords: sea anemone; venom; toxin; molecular scaffold; neurotoxin; cytotoxin; enzyme 1. Introduction Sea anemones, sometimes poetically referred to as the flowers of the sea, are exclusively marine animals that belong to the phylum Cnidaria (Figure 1A). Essentially laminar organisms, their two- dimensional epithelial construction has shaped their behavioural and physiological responses and has led to great ecological success despite their structural simplicity, as evidenced by their presence in all marine ecosystems. -
A Genomic and Proteomic Study of Sea Anemones and Jellyfish from Portugal”
A Genomic and Proteomic Study of Sea Anemones and Jellyfish from Portugal D Bárbara Frazão Biology Faculty of Sciences 2016 Supervisor Agostinho Antunes, Auxiliary Professor Faculty of Sciences of Porto University Co-supervisor Vitor Vasconcelos, Cathedratic Professor Faculty of Sciences of Porto University FCUP i “An expert is a person who has made all the mistakes that can be made in a very narrow field” Niels Bohr (Nobel Prize in Physics in 1922) FCUP ii FCUP iii Acknowledgments Acknowledgments First, I would like to express my sincere gratitude to my hosting institutions such as: Faculty of Sciences of Porto University, CIIMAR and to the financial supports of Foundation for Science and Technology “Fundação para a Ciência e a Tecnologia” (FCT), trough my PhD grant (SFRH/BD/48184/2008), the Strategic Funding UID/Multi/04423/2013 through national funds provided by FCT and the European Regional Development Fund (ERDF) in the framework of the program PT2020, by the European Structural and Investment Funds (ESIF) through the Competitiveness and Internationalization Operational Program - COMPETE 2020 and by National Funds through the FCT under the projects PTDC/AAG-GLO/6887/2014 (POCI-01-0124- FEDER-016845) and PTDC/MAR-BIO/0440/2014 (POCI-01-0145-FEDER-016772), and by the Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the ERDF. I would like to specially acknowledge my supervisor, Professor Agostinho Antunes for providing me all the resources necessary for the execution of the work presented in this dissertation. -
Evolution and Diversification of the Cnidarian Venom System Mahdokht Jouiaei Doctor of Pharmacy (Pharm.D)
Evolution and diversification of the cnidarian venom system Mahdokht Jouiaei Doctor of Pharmacy (Pharm.D) A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2016 School of Biological Sciences Abstract The phylum Cnidaria (corals, sea pens, sea anemones, jellyfish and hydroids) is the oldest venomous animal lineage (~750 million years old), making it an ideal phylum to understand the origin and diversification of venom. Cnidarians are characterised by specialised cellular structures called cnidae, which they utilise to inject mixtures of bioactive compounds or venom for predation and defence. In recent years cnidarian venoms have begun to be investigated as a potential source of novel bioactive therapeutics. However, in comparison with several venomous lineages that are relatively younger, such as snakes, cone snails and spiders, the diversification and molecular evolutionary regimes of toxins encoded by these fascinating and ancient animals remain poorly understood. The first experimental part of this thesis (Chapter 2) is comprised of the phylogenetic and molecular evolutionary histories of pharmacologically characterised cnidarian toxin families. These include peptide neurotoxins (voltage-gated Na+ and K+ channel-targeting toxins: NaTxs and KTxs, respectively), pore-forming toxins (actinoporins, aerolysin-related toxins, and jellyfish toxins) and small cysteine-rich peptides (SCRiPs). Our analyses show that most cnidarian toxins remain conserved under the strong influence of negative selection. A deeper analysis of the molecular evolutionary histories of neurotoxins demonstrates that type III KTxs have evolved from NaTxs under the regime of positive selection and likely represent a unique evolutionary innovation of the Actinioidea lineage. We also identify a few functionally important sites in other classes of neurotoxins and pore-forming toxins that experienced episodic adaptation. -
Cnidarian Peptide Neurotoxins: a New Source of Various Ion Channel
Drug Discovery Today Volume 24, Number 1 January 2019 REVIEWS Cnidarian peptide neurotoxins: a new source of various ion channel GENE TO SCREEN modulators or blockers against central nervous systems disease Reviews z z Qiwen Liao , Yu Feng , Binrui Yang and Simon Ming-Yuen Lee State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China Cnidaria provide the largest source of bioactive peptides for new drug development. The venoms contain enzymes, potent pore-forming toxins and neurotoxins. The neurotoxins can immobilize predators rapidly when discharged via modifying sodium-channel-gating or blocking the potassium channel during the repolarization stage. Most cnidarian neurotoxins remain conserved under the strong influence of negative selection. Neuroactive peptides targeting the central nervous system through affinity with ion channels could provide insight leading to drug treatment of neurological diseases, which arise from ion channel dysfunctions. Although marine resources offer thousands of possible peptides, only one peptide derived from Cnidaria: ShK-186, also named dalazatide, has reached the pharmaceutical market. This review focuses on neuroprotective agents derived from cnidarian neurotoxic peptides. Introduction to target enzymes, ion channels, receptors or transporters in the Venoms are complex cocktails involving a range of molecules, central or peripheral nervous system (e.g., ACV-1, CGX-1007, such as large proteins, small peptides, polyamines and salts, that CGX-1160, CNSB004, RPI-78M, RPI-MN, ShK-186, THA 901 and disrupt the physiology of prey animals upon injection [1]. Venom Xen2174) [9–16]. peptides and proteins have been honed by millions of years of In the phylum Cnidaria (sea anemones, corals, jellyfish and evolutionary pressure to bind their receptors with high affinity, hydra) all members are venomous [17].